Vaccines for COVID-19 were developed with unprecedented speed, but it still wasn’t fast enough for those who fell victim to the virus. Antiviral drugs could have served as primary tools for combatting infection during this time. And unlike most vaccines, they can be rapidly distributed without refrigeration and at modest cost. How can we be better prepared with antiviral drugs for the next pandemic? This panel will discuss the preemptive groundwork for creating readily available drugs for viruses most likely to drive the next global pandemic.
Learn more: [ Ссылка ]
